Article

Medicines Development to provide development support to consortium of Australian and New Zealand research teams following $6.8 million Wellcome Trust (UK) seeding drug discovery award

June 3, 2013

Researchers at the Peter MacCallum Cancer Centre, The Auckland Cancer Society Research Centre, Monash University School of Biomedical Sciences and the Queensland Institute of Medical Research aim to develop a new class of immune-suppressive drugs that protect transplanted bone marrow stem cells against immune destruction.

Medicines Development is pleased to be providing drug development expertise and project management for the team.

Further information from Monash University School of Biomedical Sciences and Queensland Institute of Medical Research.

REFERENCES

Stay up to date

Follow our work by signing up for our newsletter

Thank you, your submission has been received.
Oops! Something went wrong while submitting the form.